Wiesenfeld H C, Heine R P, Rideout A, Macio I, DiBiasi F, Sweet R L
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, Pittsburgh, PA, USA.
Am J Obstet Gynecol. 1996 May;174(5):1542-6. doi: 10.1016/s0002-9378(96)70603-8.
We evaluated the vaginal introitus as a noninvasive sampling site for testing for Chlamydia trachomatis.
Swabs from the vaginal introitus were obtained from 300 women attending a sexually transmitted diseases clinic and tested for the presence of Chlamydia trachomatis by polymerase chain reaction. Additionally, 200 of these women self-collected an additional introitus swab and submitted a urine sample for polymerase chain reaction testing. These samples were compared with polymerase chain reaction, culture, and enzyme immunoassay for Chlamydia trachomatis from endocervical samples and polymerase chain reaction and culture on urethral swabs. Patients were determined to be infected with Chlamydia trachomatis by a positive culture result from any site or a confirmed positive result by polymerase chain reaction with an alternate primer.
The sensitivity of vaginal introitus swabs obtained by health care providers for the detection of urogenital Chlamydia trachomatis was 92% (95% confidence interval 83 to 100), greater than polymerase chain reaction, culture, or enzyme immunoassay of the cervix or urethra. The sensitivity by polymerase chain reaction of patient self-collected swabs was 81%. Sampling of the vaginal introitus, by both health care workers and the patient herself, performed as well as commonly used diagnostic tests that require vaginal speculum examination. The sensitivity of polymerase chain reaction testing of urine samples was 73%.
The vaginal introitus represents a highly effective noninvasive specimen collection site for Chlamydia trachomatis testing by polymerase chain reaction. Self-collection of introitus specimens may revolutionize sexually transmitted disease testing by eliminating the need for a speculum examination by skilled health care personnel.
我们评估了阴道入口作为沙眼衣原体检测的非侵入性采样部位。
从300名就诊于性传播疾病诊所的女性获取阴道入口处的拭子,通过聚合酶链反应检测沙眼衣原体的存在。此外,其中200名女性自行采集了额外的阴道入口拭子,并提交尿液样本进行聚合酶链反应检测。将这些样本与来自宫颈样本的沙眼衣原体聚合酶链反应、培养及酶免疫测定以及尿道拭子的聚合酶链反应和培养结果进行比较。通过任何部位的阳性培养结果或使用替代引物的聚合酶链反应确诊阳性结果来确定患者感染沙眼衣原体。
医疗保健人员获取的阴道入口拭子检测泌尿生殖道沙眼衣原体的敏感性为92%(95%置信区间83%至100%),高于宫颈或尿道的聚合酶链反应、培养或酶免疫测定。患者自行采集拭子的聚合酶链反应敏感性为81%。医疗保健人员和患者本人对阴道入口的采样效果与需要阴道窥器检查的常用诊断测试相同。尿液样本聚合酶链反应检测的敏感性为73%。
阴道入口是通过聚合酶链反应检测沙眼衣原体的高效非侵入性标本采集部位。自行采集阴道入口标本可能会彻底改变性传播疾病检测方式,因为无需熟练的医疗保健人员进行窥器检查。